scholarly journals The human homologue of yeast ArgRIII protein is an inositol phosphate multikinase with predominantly nuclear localization

2002 ◽  
Vol 366 (2) ◽  
pp. 549-556 ◽  
Author(s):  
Marcus M. NALASKOWSKI ◽  
Christina DESCHERMEIER ◽  
Werner FANICK ◽  
Georg W. MAYR
Keyword(s):  
Binding Site ◽  
Mammalian Cells ◽  
Fluorescent Protein ◽  
Inositol Phosphate ◽  
Phosphate Binding ◽  
Nuclear Targeting ◽  
Calculated Molecular Mass ◽  
Atp Binding Site ◽  
C Terminus ◽  
Protein Tag

The function of the transcription regulator ArgRIII in the expression of several genes involved in the metabolism of arginine in yeast has been well studied. It was previously reported that it is also an inositol phosphate multikinase and an important factor of the mRNA export pathway [reviewed by Shears (2000) Bioessays 22, 786–789]. In the present study we report the cloning of a full-length 1248-bp cDNA encoding a human inositol phosphate multikinase (IPMK). This protein has a calculated molecular mass of 47.219kDa. Functionally important motifs [inositol phosphate-binding site, ATP-binding site, catalytically important SSLL (Ser-Ser-Leu-Leu) domain] are conserved between the human IPMK and yeast ArgRIII. Bacterially expressed protein demonstrated an inositol phosphate multikinase activity similar to that of yeast ArgRIII. Ins(1,4,5)P3 is phosphorylated at positions 3 and 6 up to Ins(1,3,4,5,6)P5. The human IPMK fused with a fluorescent protein tag is localized predominantly in the nucleus when transiently expressed in mammalian cells. A basic cluster in the protein's C-terminus is positively involved in nuclear targeting. These findings are consistent with the concept of a nuclear inositol phosphate signalling and phosphorylation pathway in mammalian cells.

scholarly journals N-Terminal Tagging with GFP Enhances Selectivity of Agitoxin 2 to Kv1.3-Channel Binding Site

Toxins ◽  
2020 ◽  
Vol 12 (12) ◽  
pp. 802
Author(s):  
Oksana V. Nekrasova ◽  
Alexandra L. Primak ◽  
Anastasia A. Ignatova ◽  
Valery N. Novoseletsky ◽  
Olga V. Geras’kina ◽  
...  
Keyword(s):  
Binding Site ◽  
Fluorescent Protein ◽  
Fluorescent Proteins ◽  
Hek293 Cells ◽  
Kv1.3 Channel ◽  
C Terminus ◽  
Peptide Toxins ◽  
Fluorescent Ligands ◽  
Voltage Gated Channels ◽  
Green Fluorescent

Recently developed fluorescent protein-scorpion toxin chimeras (FP-Tx) show blocking activities for potassium voltage-gated channels of Kv1 family and retain almost fully pharmacological profiles of the parental peptide toxins (Kuzmenkov et al., Sci Rep. 2016, 6, 33314). Here we report on N-terminally green fluorescent protein (GFP)-tagged agitoxin 2 (GFP-L2-AgTx2) with high affinity and selectivity for the binding site of Kv1.3 channel involved in the pathogenesis of various (primarily of autoimmune origin) diseases. The basis for this selectivity relates to N-terminal location of GFP, since transposition of GFP to the C-terminus of AgTx2 recovered specific interactions with the Kv1.1 and Kv1.6 binding sites. Competitive binding experiments revealed that the binding site of GFP-L2-AgTx2 overlaps that of charybdotoxin, kaliotoxin 1, and agitoxin 2, the known Kv1.3-channel pore blockers. GFP-L2-AgTx2 was demonstrated to be applicable as a fluorescent probe to search for Kv1.3 pore blockers among individual compounds and in complex mixtures, to measure blocker affinities, and to visualize Kv1.3 distribution at the plasma membrane of Kv1.3-expressing HEK293 cells. Our studies show that definite combinations of fluorescent proteins and peptide blockers can result in considerable modulation of the natural blocker-channel binding profile yielding selective fluorescent ligands of certain channels.

scholarly journals Comparison of Saccharomyces cerevisiae F-BAR Domain Structures Reveals a Conserved Inositol Phosphate Binding Site

Structure ◽  
2015 ◽  
Vol 23 (2) ◽  
pp. 352-363 ◽  
Author(s):  
Katarina Moravcevic ◽  
Diego Alvarado ◽  
Karl R. Schmitz ◽  
Jon A. Kenniston ◽  
Jeannine M. Mendrola ◽  
...  
Keyword(s):  
Saccharomyces Cerevisiae ◽  
Binding Site ◽  
Inositol Phosphate ◽  
Phosphate Binding ◽  
Bar Domain ◽  
Domain Structures

ATP binding site on the C-terminus of the vanilloid receptor

2007 ◽  
Vol 465 (2) ◽  
pp. 389-398 ◽  
Author(s):  
Lenka Grycova ◽  
Zdenek Lansky ◽  
Eliska Friedlova ◽  
Viktorie Vlachova ◽  
Martin Kubala ◽  
...  
Keyword(s):  
Binding Site ◽  
Vanilloid Receptor ◽  
Atp Binding ◽  
Atp Binding Site ◽  
C Terminus

scholarly journals The Ins(1,3,4)P3 5/6-kinase/Ins(3,4,5,6)P4 1-kinase is not a protein kinase

2005 ◽  
Vol 389 (2) ◽  
pp. 389-395 ◽  
Author(s):  
Xun Qian ◽  
Jennifer Mitchell ◽  
Sung-Jen Wei ◽  
Jason Williams ◽  
Robert M. Petrovich ◽  
...  
Keyword(s):  
Protein Kinase ◽  
Binding Site ◽  
Phosphatase Activity ◽  
Kinase Activity ◽  
Insect Cells ◽  
Inositol Phosphate ◽  
Fluid Secretion ◽  
Protein Kinase Activity ◽  
Sequence Alignments ◽  
Atp Binding Site

Among inositol phosphate kinases, Ins(3,4,5,6)P4 1-kinase has been considered to be an outsider with disparate sequence, a proclaimed capacity to also phosphorylate proteins and apparent 1-phosphatase activity. Such multifunctionality, coupled with ignorance of its operational domains, complicates any mechanistic rationale behind literature reports that Ins(3,4,5,6)P4 1-kinase regulates apoptosis, salt and fluid secretion, and transcription. We have expressed poly(His)-tagged human Ins(3,4,5,6)P4 1-kinase in Sf9 insect cells and purified the enzyme using Ni–agarose chromatography. Protein kinase activity was eluted from the Ni–agarose column, but this did not co-elute with the Ins(3,4,5,6)P4 1-kinase, indicating that the protein kinase and inositol kinase activities belong to separate proteins. To pursue this conclusion, we prepared catalytically inactive mutants of the Ins(3,4,5,6)P4 1-kinase by identifying and targeting the ATP-binding site. Our strategy was based on sequence alignments suggesting homology of the Ins(3,4,5,6)P4 1-kinase with ATP-grasp metabolic enzymes. Individual mutation of four candidate MgATP-binding participants, Lys157, Asp281, Asp295 and Asn297, severely compromised Ins(3,4,5,6)P4 1-kinase activity. Yet, these mutations did not affect the protein kinase activity. We conclude that the Ins(3,4,5,6)P4 1-kinase is not a protein kinase, contrary to earlier reports [e.g. Wilson, Sun, Cao and Majerus (2001) J. Biol. Chem. 276, 40998–41004]. Elimination of protein kinase activity from the enzyme's repertoire and recognition of its ATP-grasp homology together indicate that structural, functional and catalytic relationships between Ins(3,4,5,6)P4 1-kinase and other inositol phosphate kinases are closer than previously thought [Gonzalez, Schell, Letcher, Veprintsev, Irvine and Williams (2004) Mol. Cell 15, 689–701].

scholarly journals Evidence for a Menkes-like protein with a nuclear targeting sequence

2000 ◽  
Vol 350 (3) ◽  
pp. 855-863 ◽  
Author(s):  
Manchi C. M. REDDY ◽  
Sudeep MAJUMDAR ◽  
Edward D. HARRIS
Keyword(s):  
Cell Nucleus ◽  
Mammalian Cells ◽  
Fluorescent Protein ◽  
Chinese Hamster Ovary Cells ◽  
Chinese Hamster ◽  
Menkes Disease ◽  
Transcript Variant ◽  
Nuclear Localization Sequence ◽  
Nuclear Targeting ◽  
Metal Binding Domain

Extracts from three human cell lines were found to contain abridged Menkes disease gene transcripts with novel insertion sequences. The transcript variant that is the focus of the present study codes for a 103-residue protein containing the first heavy-metal-binding domain (Hmb1) of ATP7A, the Cu-ATPase associated with Menkes disease. This transcript variant has a 45-bp nucleotide insert interposed between exons 1 and 2 of ATP7A that starts with a 5´ ATG that is in-frame with the downstream ATG translation start site of ATP7A. We report here that the 66-bp nucleotides positioned between the upstream and downstream ATG sites encode 22 amino acid residues whose primary structure in part meets the criteria for a nuclear-localization sequence (NLS). We have referred to the transcript as nuclear Menkes-like (NML) 45. A green fluorescent protein (GFP) construct with NML45 when transfected in Chinese hamster ovary cells localized to the cell nucleus. A similar construct without the 66-bp segment exhibited a random dispersed fluorescent pattern in the cytosol. GFP constructs encoding ATP7A exons likewise failed to direct GFP into the cell nucleus, suggesting the nuclear determinant is not in an internal domain of the protein. The data suggest that the 22-residue segment contains an NLS for an 11.2-kDa protein with one Cu-binding site that may function as a chaperone to transport Cu into the nucleus of mammalian cells.

The human inositol phosphate multikinase (IPMK) is targeted to the nucleus of mammalian cells by a basic cluster in its C-terminus

2002 ◽  
Vol 2002 (Fall) ◽  
Author(s):  
Marcus Nalaskowski ◽  
Christina Deschermeier ◽  
Georg Mayr ◽  
Werner Fanick
Keyword(s):  
Mammalian Cells ◽  
Inositol Phosphate ◽  
Basic Cluster ◽  
C Terminus

scholarly journals Kinesin-like Protein CHO1 Is Required for the Formation of Midbody Matrix and the Completion of Cytokinesis in Mammalian Cells

2002 ◽  
Vol 13 (6) ◽  
pp. 1832-1845 ◽  
Author(s):  
Jurgita Matuliene ◽  
Ryoko Kuriyama
Keyword(s):  
Binding Site ◽  
Mammalian Cells ◽  
Cytoplasmic Bridge ◽  
Central Spindle ◽  
Atp Binding Site ◽  
Daughter Cells ◽  
Dividing Cells ◽  
Spindle Midzone ◽  
Segregation Of Chromosomes

CHO1 is a mammalian kinesin-like motor protein of the MKLP1 subfamily. It associates with the spindle midzone during anaphase and concentrates to a midbody matrix during cytokinesis. CHO1 was originally implicated in karyokinesis, but the invertebrate homologues of CHO1 were shown to function in the midzone formation and cytokinesis. To analyze the role of the protein in mammalian cells, we mutated the ATP-binding site of CHO1 and expressed it in CHO cells. Mutant protein (CHO1F′) was able to interact with microtubules via ATP-independent microtubule-binding site(s) but failed to accumulate at the midline of the central spindle and affected the localization of endogenous CHO1. Although the segregation of chromosomes, the bundling of midzone microtubules, and the initiation of cytokinesis proceeded normally in CHO1F′-expressing cells, the completion of cytokinesis was inhibited. Daughter cells were frequently entering interphase while connected by a microtubule-containing cytoplasmic bridge from which the dense midbody matrix was missing. Depletion of endogenous CHO1 via RNA-mediated interference also affected the formation of midbody matrix in dividing cells, caused the disorganization of midzone microtubules, and resulted in abortive cytokinesis. Thus, CHO1 may not be required for karyokinesis, but it is essential for the proper midzone/midbody formation and cytokinesis in mammalian cells.

scholarly journals Evidence for the ability of nucleophosmin/B23 to bind ATP

1998 ◽  
Vol 329 (3) ◽  
pp. 539-544 ◽  
Author(s):  
H. Jei CHANG ◽  
Y. Jui LIN ◽  
H. Ming WU ◽  
Y. M. Benjamin YUNG
Keyword(s):  
Binding Site ◽  
Protein Molecule ◽  
Atp Binding ◽  
Nitrocellulose Membrane ◽  
Atp Binding Site ◽  
Nuclear Extracts ◽  
C Terminus ◽  
Number Of Binding Sites ◽  
B23 Protein ◽  
Binding Sequence

By taking advantage of its ability to be retained by ATP-agarose, we have demonstrated that nucleophosmin/B23 is capable of binding ATP. The specificity of the binding was confirmed by the absence of significant binding to AMP-agarose and by its loss when nucleophosmin/B23 in nuclear extracts was preincubated with ATP. Preincubation of the nuclear extracts with other ribonucleotide triphosphates (GTP, CTP, UTP) did not compete for the binding of nucleophosmin/B23 to ATP-agarose. The purified recombinant nucleophosmin/B23 was also able to be retained by ATP-agarose. The Kd for binding of ATP to the purified recombinant nucleophosmin/B23, on the basis of retention on a nitrocellulose membrane, was 86.5±8.3 μM; the number of binding sites was 0.68 per nucleophosmin/B23 protein molecule. To determine the possible ATP-binding site of nucleophosmin/B23, various deletion clones including the two mutants in which the putative ATP-binding sequence had been deleted were constructed. Deletion of the portions of the molecule (residues 83-152 and 185-240) had little effect on the ATP binding. The C-terminal deleted mutant (residue 242 to the C-terminus deleted) lost most of its ability to be retained by ATP-agarose and to bind [α-32P]ATP on a nitrocellulose membrane. The results indicate that the C-terminal portion (residues 242-294) contains the essential ATP-binding site of nucleophosmin/B23.

scholarly journals Solubilization and separation of inositol 1,3,4,5-tetrakisphosphate- and inositol 1,4,5-trisphosphate-binding proteins and metabolizing enzymes in rat brain

1990 ◽  
Vol 267 (2) ◽  
pp. 441-445 ◽  
Author(s):  
A B Theibert ◽  
S Supattapone ◽  
C D Ferris ◽  
S K Danoff ◽  
R K Evans ◽  
...  
Keyword(s):  
Binding Site ◽  
Rat Brain ◽  
Molecular Species ◽  
Binding Proteins ◽  
Inositol Phosphate ◽  
Second Messenger ◽  
Phosphate Binding ◽  
Metabolizing Enzymes ◽  
High Affinity ◽  
Inositol 1,4,5 Trisphosphate

The two inositol phosphate-binding proteins, the Ins(1,4,5)P3 (InsP3) and Ins(1,3,4,5)P4 (InsP4) receptors, and the two particulate InsP3-metabolizing enzymes, InsP3 5-phosphatase and InsP3 3-kinase, were solubilized with detergent from rat cerebellar membranes. These four activities are shown to be distinct molecular species by separation using a variety of protein chromatographic steps. The pharmacology of the partially purified InsP4-binding site indicates that the binding has a high affinity and selectivity for InsP4 over InsP3. These results suggest the existence of a distinct specific InsP4-binding protein which may represent the receptor for this putative second messenger.

New Mechanistic Insight on the PIM-1 Kinase Inhibitor AZD1208 Using Multidrug Resistant Human Erythroleukemia Cell Lines and Molecular Docking Simulations

2019 ◽  
Vol 19 (11) ◽  
pp. 914-926 ◽  
Author(s):  
Maiara Bernardes Marques ◽  
Michael González-Durruthy ◽  
Bruna Félix da Silva Nornberg ◽  
Bruno Rodrigues Oliveira ◽  
Daniela Volcan Almeida ◽  
...  
Keyword(s):  
Molecular Docking ◽  
Binding Site ◽  
Cell Lines ◽  
Chemotherapeutic Agents ◽  
Atp Binding ◽  
Human Leukemia ◽  
Atp Binding Site ◽  
Mechanistic Insight ◽  
Multiple Drugs

Background:PIM-1 is a kinase which has been related to the oncogenic processes like cell survival, proliferation, and multidrug resistance (MDR). This kinase is known for its ability to phosphorylate the main extrusion pump (ABCB1) related to the MDR phenotype.Objective:In the present work, we tested a new mechanistic insight on the AZD1208 (PIM-1 specific inhibitor) under interaction with chemotherapy agents such as Daunorubicin (DNR) and Vincristine (VCR).Materials and Methods:In order to verify a potential cytotoxic effect based on pharmacological synergism, two MDR cell lines were used: Lucena (resistant to VCR) and FEPS (resistant to DNR), both derived from the K562 non-MDR cell line, by MTT analyses. The activity of Pgp was ascertained by measuring accumulation and the directional flux of Rh123. Furthermore, we performed a molecular docking simulation to delve into the molecular mechanism of PIM-1 alone, and combined with chemotherapeutic agents (VCR and DNR).Results:Our in vitro results have shown that AZD1208 alone decreases cell viability of MDR cells. However, co-exposure of AZD1208 and DNR or VCR reverses this effect. When we analyzed the ABCB1 activity AZD1208 alone was not able to affect the pump extrusion. Differently, co-exposure of AZD1208 and DNR or VCR impaired ABCB1 activity, which could be explained by compensatory expression of abcb1 or other extrusion pumps not analyzed here. Docking analysis showed that AZD1208 is capable of performing hydrophobic interactions with PIM-1 ATP- binding-site residues with stronger interaction-based negative free energy (FEB, kcal/mol) than the ATP itself, mimicking an ATP-competitive inhibitory pattern of interaction. On the same way, VCR and DNR may theoretically interact at the same biophysical environment of AZD1208 and also compete with ATP by the PIM-1 active site. These evidences suggest that AZD1208 may induce pharmacodynamic interaction with VCR and DNR, weakening its cytotoxic potential in the ATP-binding site from PIM-1 observed in the in vitro experiments.Conclusion:Finally, the current results could have a pre-clinical relevance potential in the rational polypharmacology strategies to prevent multiple-drugs resistance in human leukemia cancer therapy.

Sign in / Sign up

Export Citation Format

Share Document